Literature DB >> 28441502

Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.

Mavis Jiarong Li1, Abhinav Nath1, William M Atkins1.   

Abstract

The ATP binding cassette transporter P-glycoprotein (ABCB1 or P-gp) plays a major role in cellular resistance to drugs and drug interactions. Experimental studies support a mechanism with nucleotide-dependent fluctuation between inward-facing and outward-facing conformations, which are coupled to nucleotide hydrolysis. However, detailed insight into drug-dependent modulation of these conformational ensembles is lacking. Different drugs likely occupy partially overlapping but distinct sites and are therefore variably coupled to nucleotide binding and hydrolysis. Many fluorescent drug analogues are used in cell-based transport models; however, their specific interactions with P-gp have not been studied, and this limits interpretation of transport assays in terms of molecular models. Here we monitor binding of the fluorescent probe substrates BODIPY-verapamil, BODIPY-vinblastine, and Flutax-2 at low occupancy to murine P-gp in lipid nanodiscs via fluorescence correlation spectroscopy, in variable nucleotide-bound states. Changes in affinity for the different nucleotide-dependent conformations are probe-dependent. For BODIPY-verapamil and BODIPY-vinblastine, there are 2-10-fold increases in KD in the nucleotide-bound or vanadate-trapped state, compared to that in the nucleotide-free state. In contrast, the affinity of Flutax-2 is unaffected by nucleotide or vanadate trapping. In further contrast to BODIPY-verapamil and BODIPY-vinblastine, Flutax-2 does not cause stimulation of ATP hydrolysis despite the fact that it is transported in vesicle-based transport assays. Whereas the established substrates verapamil, paclitaxel, and vinblastine displace BODIPY-verapamil or BODIPY-vinblastine from their high-affinity sites, the transport substrate Flutax-2 is not displaced by any of these substrates. The results demonstrate a unique binding site for Flutax-2 that allows for transport without stimulation of ATP hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28441502      PMCID: PMC5701749          DOI: 10.1021/acs.biochem.6b01245

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2.

Authors:  Tasha K Ritchie; Hyewon Kwon; William M Atkins
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 3.  The ATP switch model for ABC transporters.

Authors:  Christopher F Higgins; Kenneth J Linton
Journal:  Nat Struct Mol Biol       Date:  2004-10       Impact factor: 15.369

4.  P-glycoprotein catalytic mechanism: studies of the ADP-vanadate inhibited state.

Authors:  Ina L Urbatsch; Grace A Tyndall; Gregory Tombline; Alan E Senior
Journal:  J Biol Chem       Date:  2003-04-01       Impact factor: 5.157

5.  Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins.

Authors:  N Lerner-Marmarosh; K Gimi; I L Urbatsch; P Gros; A E Senior
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

6.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

Review 7.  Structure and mechanism of ABC transporter proteins.

Authors:  Kaspar Hollenstein; Roger J P Dawson; Kaspar P Locher
Journal:  Curr Opin Struct Biol       Date:  2007-08-27       Impact factor: 6.809

8.  A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases.

Authors:  S Chifflet; A Torriglia; R Chiesa; S Tolosa
Journal:  Anal Biochem       Date:  1988-01       Impact factor: 3.365

9.  Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport.

Authors:  Muhammad Waqas Sadiq; Yasuo Uchida; Yutaro Hoshi; Masanori Tachikawa; Tetsuya Terasaki; Margareta Hammarlund-Udenaes
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

10.  Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein.

Authors:  Paul Szewczyk; Houchao Tao; Aaron P McGrath; Mark Villaluz; Steven D Rees; Sung Chang Lee; Rupak Doshi; Ina L Urbatsch; Qinghai Zhang; Geoffrey Chang
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-02-26
View more
  9 in total

1.  Conformational dynamics of P-glycoprotein in lipid nanodiscs and detergent micelles reveal complex motions on a wide time scale.

Authors:  Mavis Jiarong Li; Miklos Guttman; William M Atkins
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

2.  Preparation of Lipid Nanodiscs with Lipid Mixtures.

Authors:  Mavis Jiarong Li; William M Atkins; Wynton D McClary
Journal:  Curr Protoc Protein Sci       Date:  2019-12

3.  Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity.

Authors:  Yi-Ting Zhang; Yu-Qi Yu; Xiao-Xia Yan; Wen-Jie Wang; Xiao-Ting Tian; Le Wang; Wei-Liang Zhu; Li-Kun Gong; Guo-Yu Pan
Journal:  Acta Pharmacol Sin       Date:  2018-11-15       Impact factor: 6.150

4.  Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).

Authors:  Andaleeb Sajid; Natarajan Raju; Sabrina Lusvarghi; Shahrooz Vahedi; Rolf E Swenson; Suresh V Ambudkar
Journal:  Drug Metab Dispos       Date:  2019-08-01       Impact factor: 3.922

5.  The critical size of gold nanoparticles for overcoming P-gp mediated multidrug resistance.

Authors:  Yuqian Jiang; Zheng Wang; Wei Duan; Lingyan Liu; Mahan Si; Xiaoyuan Chen; Chen-Jie Fang
Journal:  Nanoscale       Date:  2020-06-17       Impact factor: 7.790

6.  Application of fluorescence correlation spectroscopy to study substrate binding in styrene maleic acid lipid copolymer encapsulated ABCG2.

Authors:  Aaron J Horsey; Deborah A Briggs; Nicholas D Holliday; Stephen J Briddon; Ian D Kerr
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-02-11       Impact factor: 3.747

7.  Dynamics of ABC Transporter P-glycoprotein in Three Conformational States.

Authors:  Noah Kopcho; Geoffrey Chang; Elizabeth A Komives
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

8.  Long Range Communication between the Drug-Binding Sites and Nucleotide Binding Domains of the Efflux Transporter ABCB1.

Authors:  Amanda F Clouser; William M Atkins
Journal:  Biochemistry       Date:  2022-04-06       Impact factor: 3.321

Review 9.  Biophysical Characterization of Membrane Proteins Embedded in Nanodiscs Using Fluorescence Correlation Spectroscopy.

Authors:  Matthew J Laurence; Timothy S Carpenter; Ted A Laurence; Matthew A Coleman; Megan Shelby; Chao Liu
Journal:  Membranes (Basel)       Date:  2022-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.